{"id":"https://openalex.org/W178692011","doi":null,"title":"Prospects for non-immunological molecular therapeutics in melanoma.","display_name":"Prospects for non-immunological molecular therapeutics in melanoma.","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W178692011","mag":"178692011","pmid":"https://pubmed.ncbi.nlm.nih.gov/20414921"},"language":"en","primary_location":{"id":"pmid:20414921","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20414921","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://doras.dcu.ie/15583/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011649305","display_name":"Alex J. Eustace","orcid":"https://orcid.org/0000-0002-4092-1360","observed_orcids":["https://orcid.org/0000-0002-4092-1360"]},"institutions":[{"id":"https://openalex.org/I42934936","display_name":"Dublin City University","ror":"https://ror.org/04a1a1e81","country_code":"IE","type":"education","lineage":["https://openalex.org/I42934936"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"A J Eustace","raw_affiliation_strings":["National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland. norma.odonovan@dcu.ie"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland. norma.odonovan@dcu.ie","institution_ids":["https://openalex.org/I42934936"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112248591","display_name":"Thamir Mahgoub","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Mahgoub","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029704952","display_name":"Dimitrios J. Tryfonopoulos","orcid":"https://orcid.org/0000-0003-3650-8247","observed_orcids":["https://orcid.org/0000-0003-3650-8247"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Tryfonopoulos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021160836","display_name":"Norma O\u2019Donovan","orcid":"https://orcid.org/0000-0003-1113-3872","observed_orcids":["https://orcid.org/0000-0003-1113-3872"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N O'Donovan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5043292277","display_name":"John Paul Crown","orcid":"https://orcid.org/0000-0002-3125-7613","observed_orcids":["https://orcid.org/0000-0002-3125-7613"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Crown","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3186,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.50537976,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"15","issue":"1","first_page":"9","last_page":"18"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8399999737739563},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.8629999756813049},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.8600000143051147},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.7789999842643738},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.949999988079071},{"id":"https://openalex.org/keywords/pi3-akt-pathway","display_name":"PI3/Akt pathway","score":0.9779999852180481},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9210000038146973},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.8740000128746033},{"id":"https://openalex.org/keywords/poly-adp-ribose-polymerase","display_name":"poly(ADP-ribose) polymerase","score":0.9070000052452087},{"id":"https://openalex.org/keywords/survivin","display_name":"survivin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hsp90","display_name":"HSP90","score":0.972000002861023},{"id":"https://openalex.org/keywords/novel-therapeutic-targets","display_name":"novel therapeutic targets","score":0.5550000071525574}],"concepts":[{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7796744108200073},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.7151408195495605},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.69541335105896},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6558637619018555},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.5442885756492615},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.524071455001831},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4631713032722473},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.44964516162872314},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.4325740933418274},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.4146699011325836},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.38624492287635803},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3537229001522064},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33460497856140137},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.31380388140678406},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2736619710922241},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20714455842971802},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:20414921","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20414921","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","raw_type":"Journal Article"},{"id":"pmh:http://www.rian.ie/42479/","doi":null,"is_oa":true,"landing_page_url":"http://doras.dcu.ie/15583/","pdf_url":"http://doras.dcu.ie/15583/","source":{"id":"https://openalex.org/S4306400033","display_name":"Arrow@dit (Dublin Institute of Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210144925","host_organization_name":"Technological University Dublin","host_organization_lineage":["https://openalex.org/I4210144925"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Eustace, Alexander J., Mahgoub, Thamir, Tryfonopoulos, Dimitrios, O'Donovan, Norma and Crown, John (2010) Prospects for non-immunological molecular therapeutics in melanoma. Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 15 (Jan-Ma). pp. 9-18. ISSN 1107-0625","raw_type":"Other"},{"id":"pmh:oai:doras.dcu.ie:15583","doi":null,"is_oa":true,"landing_page_url":"https://doras.dcu.ie/15583/2/Melanoma_review_article_17_08_09-FINAL.pdf","pdf_url":"https://doras.dcu.ie/15583/2/Melanoma_review_article_17_08_09-FINAL.pdf","source":{"id":"https://openalex.org/S4306401511","display_name":"Dublin City University Open Access Institutional Repository (Dublin City University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I42934936","host_organization_name":"Dublin City University","host_organization_lineage":["https://openalex.org/I42934936"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"pmh:http://www.rian.ie/42479/","doi":null,"is_oa":true,"landing_page_url":"http://doras.dcu.ie/15583/","pdf_url":"http://doras.dcu.ie/15583/","source":{"id":"https://openalex.org/S4306400033","display_name":"Arrow@dit (Dublin Institute of Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210144925","host_organization_name":"Technological University Dublin","host_organization_lineage":["https://openalex.org/I4210144925"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Eustace, Alexander J., Mahgoub, Thamir, Tryfonopoulos, Dimitrios, O'Donovan, Norma and Crown, John (2010) Prospects for non-immunological molecular therapeutics in melanoma. Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 15 (Jan-Ma). pp. 9-18. ISSN 1107-0625","raw_type":"Other"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W178692011.pdf","grobid_xml":"https://content.openalex.org/works/W178692011.grobid-xml"},"referenced_works_count":120,"referenced_works":["https://openalex.org/W1571264139","https://openalex.org/W1829794674","https://openalex.org/W1870720170","https://openalex.org/W1877440701","https://openalex.org/W1934287581","https://openalex.org/W1970700441","https://openalex.org/W1971282686","https://openalex.org/W1973966923","https://openalex.org/W1977979223","https://openalex.org/W1980431726","https://openalex.org/W1985036347","https://openalex.org/W1985068997","https://openalex.org/W1987407561","https://openalex.org/W1987409389","https://openalex.org/W1988219667","https://openalex.org/W1988620734","https://openalex.org/W1988698939","https://openalex.org/W1991196199","https://openalex.org/W1991541715","https://openalex.org/W1996112634","https://openalex.org/W1997928510","https://openalex.org/W1999198216","https://openalex.org/W2003973314","https://openalex.org/W2004792969","https://openalex.org/W2006808266","https://openalex.org/W2006850592","https://openalex.org/W2007345690","https://openalex.org/W2008677826","https://openalex.org/W2010980929","https://openalex.org/W2012026523","https://openalex.org/W2012701739","https://openalex.org/W2022952582","https://openalex.org/W2024262880","https://openalex.org/W2025486703","https://openalex.org/W2027857593","https://openalex.org/W2028138723","https://openalex.org/W2030443648","https://openalex.org/W2031111848","https://openalex.org/W2031718947","https://openalex.org/W2032751670","https://openalex.org/W2034048944","https://openalex.org/W2034516953","https://openalex.org/W2036500143","https://openalex.org/W2040189554","https://openalex.org/W2047067305","https://openalex.org/W2052370726","https://openalex.org/W2055846628","https://openalex.org/W2059148084","https://openalex.org/W2060317877","https://openalex.org/W2060809474","https://openalex.org/W2062289724","https://openalex.org/W2065392301","https://openalex.org/W2066179587","https://openalex.org/W2068944371","https://openalex.org/W2069023201","https://openalex.org/W2070396671","https://openalex.org/W2072568732","https://openalex.org/W2075650416","https://openalex.org/W2075786845","https://openalex.org/W2078519247","https://openalex.org/W2080313922","https://openalex.org/W2080483074","https://openalex.org/W2084060660","https://openalex.org/W2087012714","https://openalex.org/W2089168156","https://openalex.org/W2090398284","https://openalex.org/W2096814137","https://openalex.org/W2097373408","https://openalex.org/W2098587255","https://openalex.org/W2098844933","https://openalex.org/W2100677570","https://openalex.org/W2102820712","https://openalex.org/W2103027517","https://openalex.org/W2103786597","https://openalex.org/W2107077893","https://openalex.org/W2107417489","https://openalex.org/W2109545153","https://openalex.org/W2111888201","https://openalex.org/W2114024312","https://openalex.org/W2115851907","https://openalex.org/W2116725504","https://openalex.org/W2117263216","https://openalex.org/W2120807471","https://openalex.org/W2121356082","https://openalex.org/W2127120957","https://openalex.org/W2129318139","https://openalex.org/W2129683402","https://openalex.org/W2131384028","https://openalex.org/W2137903987","https://openalex.org/W2138215232","https://openalex.org/W2139281532","https://openalex.org/W2139684524","https://openalex.org/W2141041901","https://openalex.org/W2142967975","https://openalex.org/W2143974518","https://openalex.org/W2144768837","https://openalex.org/W2148346149","https://openalex.org/W2154196978","https://openalex.org/W2155305032","https://openalex.org/W2156266404","https://openalex.org/W2158305336","https://openalex.org/W2158495245","https://openalex.org/W2161724145","https://openalex.org/W2164699117","https://openalex.org/W2166419546","https://openalex.org/W2168377349","https://openalex.org/W2172124462","https://openalex.org/W2177540787","https://openalex.org/W2183964012","https://openalex.org/W2188965426","https://openalex.org/W2246768598","https://openalex.org/W2264912071","https://openalex.org/W2266575112","https://openalex.org/W2273048576","https://openalex.org/W2277530278","https://openalex.org/W2318054354","https://openalex.org/W2339455722","https://openalex.org/W2412322598","https://openalex.org/W2415634072","https://openalex.org/W3135115018"],"related_works":["https://openalex.org/W2017844495","https://openalex.org/W2111863560","https://openalex.org/W2314887516","https://openalex.org/W2132876743","https://openalex.org/W2125038885","https://openalex.org/W2224636118","https://openalex.org/W4221022956","https://openalex.org/W35498444","https://openalex.org/W1916356108","https://openalex.org/W3159967120"],"abstract_inverted_index":{"In":[0,126],"2006":[1],"there":[2,44],"were":[3],"60,000":[4],"new":[5],"cases":[6],"of":[7,36,135,171],"cutaneous":[8],"melanoma":[9,176],"in":[10,59,63,69,83,94,109,117,121,175],"the":[11,136,149],"European":[12],"Union":[13],"and":[14,30,38,68,112,160,168],"13,000":[15],"deaths":[16],"(www.europeancancerleagues.":[17],"org).":[18],"Currently":[19],"available":[20],"systemic":[21],"treatment":[22],"options":[23],"for":[24,49],"metastatic":[25,124],"melanoma,":[26],"including":[27],"both":[28],"cytotoxic":[29],"immunologic":[31],"therapies,":[32],"produce":[33],"low":[34],"rates":[35],"response":[37],"have":[39,56],"modest":[40],"survival":[41],"impact.":[42],"Therefore,":[43],"is":[45,88,91,113],"an":[46],"urgent":[47],"need":[48],"effective":[50],"novel":[51,143,173],"therapies.":[52],"Molecularly":[53],"targeted":[54],"treatments":[55],"demonstrated":[57],"efficacy":[58],"certain":[60],"cancers":[61],"e.g.":[62],"HER2-":[64],"positive":[65],"breast":[66],"cancer":[67],"chronic":[70],"myeloid":[71],"leukaemia.":[72],"Several":[73],"pathways":[74],"are":[75,139],"currently":[76,114,145],"being":[77,115,140,146],"investigated":[78,147],"as":[79],"potential":[80],"molecular":[81],"targets":[82,103,144,174],"melanoma.":[84,95],"The":[85],"best":[86],"studied":[87],"BRAF":[89],"which":[90,102,131],"frequently":[92],"mutated":[93],"A":[96],"multi":[97],"tyrosine":[98,152],"kinase":[99],"inhibitor,":[100],"sorafenib,":[101],"BRAF,":[104,129],"has":[105],"shown":[106],"promising":[107],"activity":[108],"preclinical":[110,167],"studies":[111],"tested":[116],"combination":[118],"with":[119,123],"chemotherapy":[120],"patients":[122],"disease.":[125],"addition":[127],"to":[128],"therapies":[130],"target":[132],"other":[133],"components":[134],"Raf/Ras/MAPK":[137],"pathway":[138],"investigated.":[141],"Other":[142],"include":[148],"PI3/AKT":[150],"pathway,":[151],"kinases,":[153],"angiogenesis,":[154],"poly":[155],"(ADP":[156],"ribose)":[157],"polymerases,":[158],"survivin":[159],"heat":[161],"shock":[162],"protein":[163],"90.":[164],"Progress":[165],"on":[166],"clinical":[169],"evaluation":[170],"these":[172],"will":[177],"be":[178],"reviewed.":[179]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2016-06-24T00:00:00"}